Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease. J Nat Med - Ran, L-S; Wu, Y-Z; Gan, Y-W; Wang, H-L; Wu, L-J; Zheng, C-M (2022)